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Abstract
This paper investigates whether cannabis use leads to worse mental health. To do so, we
account for common unobserved factors aecting mental health and cannabis consumption
by modeling mental health jointly with the dynamics of cannabis use. Our main nding is
that using cannabis increases the likelihood of mental health problems, with current use
having a larger eect than past use. The estimates suggest a dose response relationship
between the frequency of recent cannabis use and the probability of currently experiencing
a mental health problem.
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1 Introduction
Cannabis is the most widely used illicit drug. Over the last thirty years, the age
at which it is rst used has fallen and lifetime prevalence has risen in most devel-
oped countries (Hall, 2006). Cannabis' popularity is derived from the mild euphoria
associated with its consumption and from the generally held belief that its health
consequences are rather benign. However, there is growing evidence of an associa-
tion between mental health problems and cannabis use. What remains unclear is
whether the proper interpretation of this evidence is that cannabis use causes mental
health problems. The existence of unobserved personal characteristics or circum-
stances that causes both mental illness and cannabis use is a plausible alternative
explanation. The purpose of this paper is to investigate the nature of the relation-
ship between cannabis consumption and mental health and in so doing, determine
the extent to which cannabis use leads to worse mental health.
Establishing whether cannabis use is a cause of mental illness is of particular
interest from a policy perspective. Uptake of cannabis typically occurs during the
mid to late teens while individuals are still attending school. For example, 42% of
12th graders in the US and 32% of 12th graders in Australia have used cannabis in
their lifetime (Johnston et al., 2006; White and Hayman, 2006). If cannabis use is
a cause of mental illness, then educating adolescents about this risk may deter its
uptake and thereby reduce population levels of mental illness. While a reduction
in the prevalence of mental illness is desirable in itself, it is also likely to lead to
signicant economic benets. The World Health Organization estimates the eco-
nomic cost of mental illness to be between 3 and 4% of GNP per year for developed
countries, with around half of the cost attributed to lost productivity (WHO, 2003).
Knowledge of the mental health consequences of cannabis consumption is also useful
for informing the debate over its legal status because it would allow a more accurate
accounting of the costs and benets of maintaining its status as a criminal oense.1 Introduction 3
Given the recent moves to legalize cannabis in England and Portugal, this issue is
clearly of ongoing policy interest.
There exists a substantial literature in economics documenting the consequences
of cannabis use in terms of educational attainment, physical health and labor market
success (for overviews see Van Ours and Williams, 2009; Williams and Skeels, 2006).
Previous research on the relationship between mental health and illicit substance use,
however, comes almost entirely from epidemiology.1 The earliest attempt to identify
the causal impact of cannabis use on mental illness is by Andreasson et al. (1987)
who study a cohort of more than 50,000 18-20 year old Swedish conscripts. The
authors nd that the post-conscription risk of developing schizophrenia is increasing
in the number of times cannabis is used prior to conscription. Giving a causal
interpretation to this nding is complicated, however, by the fact that while the
prevalence of cannabis use has increased over the last 30 years in most countries,
the prevalence of schizophrenia has not (Hall, 2006; Kalant, 2004). Nonetheless,
Andreasson et al.'s (1987) research has prompted a raft of epidemiological studies
on the topic. These subsequent studies tend to consider more general measures of
mental health, including depression and anxiety. The results from this research are
mixed with some papers reporting a positive association between cannabis use and
mental health problems (Fergusson et al., 2005; Fergusson et al., 2002; Patton et al.,
2002; Rey et al., 2002; Boys et al., 2003) and others reporting no association (McGee
et al., 2000; Fergusson et al. 1997). In a meta analysis, Degenhardt et al. (2003)
found a modest but signicant association between heavy use of cannabis and later
depression. In their overview study, Arseneault et al. (2004) conclude that rates
of cannabis use are approximately twice as high among people with schizophrenia
than among the general population.
In examining the relationship between mental health and cannabis use, the lit-
1 For interesting reviews see Hall (2006); Kalant (2004); or Macleod et al. (2004).1 Introduction 4
erature cited above has attempted to identify the causal eect of cannabis use by
controlling for observed factors that may be a source of confounding.2 However, as
noted by Pudney (2010), the potential for unobserved common confounding factors
makes inference regarding the causal impact of cannabis use dicult. The purpose
of this paper is to address this issue. To do so, we use a discrete factor approach.
Our methodology marries Heckman and Singer's (1984) use of discrete factors in
addressing unobserved heterogeneity in hazard rate analysis with their use by Mroz
(1999) to account for endogenous variables in regression models. More specically,
we estimate a trivariate system of equations consisting of hazard functions for the
decision to start using cannabis and the decision to quit and a Tobit model for the
production of mental health. By allowing the distribution of discrete factors deter-
mining cannabis use dynamics and continuous mental health to be correlated, we
account for common unobserved factors and hence obtain reliable estimates of the
impact of cannabis use on mental health.
Our main nding is that frequent use of cannabis increases the likelihood of men-
tal health problems. Infrequent and past cannabis use also increases the likelihood
of mental health problems but the eects are substantially smaller. To give a sense
of the magnitude of the eects, our estimates suggest that 2.4% of males who use
cannabis weekly or more often will experience severe mental health problems com-
pared with 1.5% of males who use monthly, 1.4% of males who are past users and
0.9% of males who have never used cannabis.
The rest of this paper is laid out as follows. Section 2 describes the data used
in this study and discusses its strengths and weaknesses. Section 3 presents the
econometric methodology and results from estimation. Section 4 reports on an ex-
amination of the robustness of the results by way of an extensive sensitivity analysis.
2 Fergusson et al. (2002, 2007) are exceptions in that they also control for unobserved hetero-
geneity using xed eects models. The later paper addresses the issue of causality using models
estimated with LISREL.2 Data 5
Section 5 summarizes our ndings.
2 Data
2.1 Australian National Drug Strategy Household Survey
This research draws on information collected in the 2004 Australian National Drug
Strategy Household Survey (NDSHS). The NDSHS is managed by the Australian
Institute of Health and Welfare on behalf of the Commonwealth Department of
Health and Ageing. It is designed to provide data on awareness, attitudes and
behavior relating to licit and illicit drug use by the non-institutionalized civilian
population in Australia. The sampling framework is a multistage stratied sample
design, where stratication is based on geographic region. In each sampled house-
hold, the respondent is the person with the next birthday who is at least 12 years of
age. Self-completion questionnaires and computer assisted telephone interviewing
methodologies were used to survey respondents, with the bulk of data (82%) col-
lected by self-completion questionnaires. Of the households contacted for the Drop
and Collect Survey who fell within the scope of the study, 68% agreed to participate
and accepted a questionnaire. Seventy nine percent of these households returned the
questionnaire. However, only 66% of the returned surveys were deemed usable, with
the balance of questionnaires returned blank (8%) or with missing essential informa-
tion or otherwise unreliable (5%). An analysis of the prole of non-response based
on those who returned blank Drop and Collect Questionnaires indicates that this
form of non-response was most prevalent among the over sixty age group, especially
females over sixty (AIHW, 2005).
In addition to asking individuals whether they have ever used or currently use
various licit and illicit drugs, the NDSHS also asks those who report having ever used
each substance the age at which it was rst used. This, along with an \objective"2 Data 6
measure of mental health in the form of the Kessler-10 (K10) scale of psychological
distress make these data useful for examining the impact of cannabis use on mental
health outcomes.
2.2 Cannabis Use, Mental Health and Data Issues
Several measures related to cannabis consumption are used in our analysis. In
modeling cannabis use dynamics, the outcomes of interest are the age at which
cannabis was rst used and the duration of use. The age of rst use is constructed
from responses to the question, \About what age were you when you rst used
marijuana/cannabis?". This question was asked of all those who reported ever
using cannabis. While we do not have information on the age at which respondents
last used cannabis and hence duration of use, we do know whether or not they have
used in the year prior to survey. Uncertainty surrounding the duration of cannabis
use is addressed using econometric techniques which are described in section 3.
In modeling the production function for mental health, current and past use
of cannabis are the focus. These measures are directly related to the outcomes
in the dynamics of cannabis use. We dene current cannabis users as those who
have initiated into cannabis and have used at least once in the twelve months prior
to survey. Past users are dened as those who have initiated use but have not
consumed cannabis in the twelve months before being surveyed. For current users,
we also investigate whether the mental health impacts dier by the frequency with
which cannabis is used. To do this, current cannabis users are categorized as using
once or twice a year, every few months, about once a month, once a week or more, or
every day. These mutually exclusive categories form the set of potential responses to
the question \In the last 12 months, how often did you use marijuana/cannabis?".
The measure of mental health we use is the K10 scale of psychological distress.
The K10 was developed as a screening tool for non-specic psychological distress2 Data 7
for the US National Health Interview Survey (Kessler et al., 2002 and 2003). The
K10 is widely used, both as a measure of mental health status in general population
surveys and as an outcome measure in primary care settings (Pirkis et al., 2005). It
has been shown to be signicantly correlated with other instruments including the
General Health Questionnaire, the Short Form 12, the Comprehensive International
Diagnostic Interview-Short Form, and the World Health Organization Disability
Assessment Schedule (Kessler et al., 2003; Andrews and Slade, 2001). The K10
is a self-report measure of psychological distress consisting of 10 items which ask
respondents about symptoms of depression and anxiety in the past four weeks. There
is a ve level response scale that ranges from none of the time (1) to all of the time
(5). The specic items asked are as follows: \In the last four weeks, about how
often did you feel ...": 1. Tired out for no good reason? 2. Nervous? 3. So nervous
that nothing could calm you down? 4. Hopeless? 5. Restless or dgety? 6. So
restless you could not sit still? 7. Depressed? 8. That everything was an eort?
9. So sad that nothing could cheer you up? 10. Worthless? The sum of scored
responses to the 10 questions is used to generate a single \score" of psychological
distress ranging from 10 to 50. A score under 20 indicates that the respondent is
likely to be well, a score of 20-24 indicates a mild mental disorder, a score of 25-29
indicates a moderate disorder and a score of 30 or greater indicates a severe mental
disorder.3
As with previous research studying transitions in substance use with cross-
sectional data, this study is subject to potential measurement error problems as-
sociated with recall error. As discussed below, we nd some evidence of recall error
in the reported age of initiation into cannabis use for those who report initiating
after the age of 25. To the extent that respondent's make errors in the age they
report rst using cannabis, our parameter estimates are likely to be biased towards
3 These cut-os are recommended for Australian General Practitioners; see:
http://www.gpcare.org/outcome%20measures/outcomemeasures.html2 Data 8
zero. Since initiation into use after the age of 25 is fairly rare, we do not anticipate
large eects from this source of measurement error. Nonetheless, we investigate the
impact of this issue on our results in a sensitivity analysis contained in section 4.
A further potential measurement issue relates to the use of the K10 score as the
measure of mental health. The K10 score items relate to symptoms experienced in
the 4 weeks prior to survey. If symptoms of mental illness are not experienced in
the relevant 4 week window, then they may go undetected by this measure.
A more serious shortcoming of the data used in our study is that, while retro-
spective information is collected about the age when cannabis was rst used, no
such information is available for the age at which symptoms of mental illness were
rst experienced or the age at which mental illness was rst diagnosed.4 Therefore,
we are unable to account for the potential for mental illness preceding, or causing,
cannabis use. Several studies from epidemiology have, however, sought to determine
whether there is a causal pathway running from mental illness to cannabis use. For
example, Fergusson et al. (2005) investigate the relationship between cannabis use
and psychotic episodes measured at ages 18, 21 and 25. They found no evidence that
psychotic episodes lead to cannabis use and some evidence that increasing psychotic
symptoms were associated with a decline in the use of cannabis. These ndings are
in line with Van Os et al. (2002) and Henquet et al. (2005) who nd no evidence
that early psychotic symptoms predict an increased risk of cannabis use, and Patton
et al. (2002) who nd that anxiety in teenagerhood does not predict later cannabis
use. McGee et al. (2000), however, nds that although cannabis use at age 18
4 As far as we have been able to determine, this weakness is not overcome in any other data. For
example, the National Longitudinal Survey of Youth 97 cohort (NLSY97) uses a ve-item short
version of the Mental Health Inventory (MHI) to rst assess mental health (in the past month)
when respondents are aged 15-20 and the Christchurch Health and Development Study (CHDS)
rst asks about anxiety and depression at age 15. Thus neither study identies the age at which
mental health problems rst occur.2 Data 9
predicts mental disorders at age 21, mental disorders at age 15 predicts a small but
signicantly elevated risk of cannabis use at age 18. So, while we cannot rule out
the possibility of reverse causality, the evidence suggests that it is unlikely to have
a large eect on our estimates.
2.3 Descriptive Statistics
Our sample is composed of 4771 males and 6719 females aged 26-50 years old for
whom we have complete data on mental health, cannabis use, and the other control
variables. Summary statistics for the outcomes of interest and other explanatory
variables are reported in Table 1. Table 1 shows that 58% of males and 49% of
females in the sample have used cannabis in their lifetime. Twenty percent of males
and 11% of females have used cannabis in the past year. Therefore, according to
our denitions, 38% of males and females are past users of cannabis, while 20% of
males and 11% of females are current users of cannabis. Amongst those who have
ever used cannabis, the average age of initiation is 18.4 years for males and 18.7
years for females, with 12% of males and 9% of females initiating before the age of
16. The frequency of past year use is also reported in Table 1. For comparability
with other variables, these rates are reported as percentages of the full sample. As
shown in Table 1, 5.2% of males and 3.7% of females in our sample use cannabis
once or twice a year, 2.9% of males and 1.5% of females use every few months, 2.2%
of males and 1.3% of females use every month, 5.3% of males and 2.4% of females
use once a week, while 4.6% of males and 1.7% of females use cannabis every day.
In terms of mental health, the average K10 score for males is 14.8 and for females
it is 15.5. On the basis of their K10 score, 14% of males and 17% of females have a
mental health disorder.5
5 The Australian 2007 National Survey of Mental Health and Wellbeing collected information for
the K10 as well as diagnosing mental disorders based on the International classication of Disease -
10th Revision, Classication of Mental Health and Behavioral Disorders. It nds a high correlation2 Data 10
In terms of demographic characteristics, the average age of the sample is about
38, and close to 80% of the sample were born in Australia, with 2% identifying them-
selves as Aboriginal or Torres Strait Islanders. More than two-thirds of individuals
in the sample are currently married, and a further 10% of males and 14% of females
are divorced. In terms of education, 16% of males and 24% of females report their
highest level of educational attainment as a 10th grade education or less.
Figure 1 provides a graphical illustration of the probability of starting cannabis
use at each age, conditional on not having been a user up to that age. The gure
shows that initiation into cannabis use begins at an early age. The rst peak in the
probability of uptake is at age 16, when 10% of males and 8% of females who had
not previously used cannabis initiate use. The mean peak is at age 18, with 14% of
males and 11% of females initiating use, but there is also a peak of 10% for males
at age 20 and subsequent peaks are at age 25 and 30. The peaks at ages 25 and 30
in the age-specic starting probabilities may point to bundling in the recollection
of the starting age, although as Figure 1 shows, initiation into cannabis use rarely
occurs beyond age 25. At age 16, 12% of males and 9% of females in the sample
have started cannabis use. This increases to 54% of males and 45% of females at
age 25. By the age of 50, 58% of males and 49% of females have used cannabis at
some point in their life.
Figure 2 shows the distribution of K10 scores for males and females. By con-
struction, the K10 score has a lower bound of 10 and an upper bound of 50, with
higher scores indicating greater levels of psychological distress. The K10 score has
a right skewed distribution, with an average value around 15 for both males and fe-
males. A large proportion of observations (17% of males and 11% of females) occur
between the two instruments with 80% of those with a K10 of 30 or more being diagnosed with
having a mental disorder in the previous 12 months compared with only 11% with a score of less
than 15 being diagnosed as having a mental disorder in the past 12 months (Australian Bureau of
Statistics, 2008).2 Data 11
at the lower bound value of 10. Figure 2 also shows that the sample proportion with
each score falls as the score increases. As mentioned above, scores below 20 indicate
no mental health problems, and 86% of males and 83% of females fall within this
category. Scores in the range of 20-24 indicate mild psychological distress and 9% of
males and 10% of females fall within this category. Moderate psychological distress
is indicted by a score between 25 and 29 and severe psychological distress is indicted
by a score of 30 or greater. In this sample, 3% of males and 4% of females suer
moderate psychological distress and 2% of males and 3% of females suer severe
psychological distress according to their K10 score.
The distribution of mental health status conditional on cannabis use status (never
used, past user, current user) is shown for males and females in Table 2. Three main
points emerge from examining this table. First, there is a higher prevalence of mental
illness among current and past users of cannabis compared to those who have never
used. For example, we see that 11% of males and 14% of females who have never
used cannabis have a mental health disorder compared to 21% of males and 29% of
females who are current users. Second, past users have a lower prevalence of mental
illness than current users. For example, 13% of males and 19% of females who are
past users of cannabis are classied as having a mental health disorder compared to
21% of males and 29% of females who are current users. The third stylized fact that
emerges from Table 2 is that females are more likely than males to suer mental
illness.
The above discussion demonstrates an association between cannabis use and
mental health problems that appears to dier between past and current use. The
analysis that follows attempts to discern the degree to which this relationship is
causal.3 Empirical Strategy 12
3 Empirical Strategy
The decision to start and stop using cannabis as well as the likelihood of experienc-
ing mental illness may be eected by many personal characteristics in addition to
circumstances faced in childhood and early adulthood. The most signicant chal-
lenge posed in investigating potential links between cannabis use and mental health
is the impossibility of observing all the personal characteristics and circumstances
that might be relevant. According to Pudney (2010) even the most comprehensive
longitudinal survey cannot hope to measure every relevant aspect of the individual
and his or her environment. Nevertheless, in order to be able to assess the potential
causal link between cannabis use and mental health common unobserved \confound-
ing" factors that may be a source of spurious association must be taken into account.
It is dicult, if not impossible, to identify characteristics or circumstances that aect
cannabis use but not mental health, rendering the use of instrumental variable tech-
niques is infeasible.6 Instead we exploit the discrete factor approach. This method
for allowing for correlation in unobservables across multiple equations without im-
posing distributional assumptions has been used in a wide variety of applications
in health and labor economics (see for example, Cutler 1995; Bray 2005; Van Ours
2006, 2007; Yang, Gilleskie and Norton 2009).
The discrete factor approach was proposed by Heckman and Singer (1984) to
address unobserved heterogeneity in hazard rate analysis. It has been further devel-
6 Note that policy variables relating to cannabis use, such as its legal status and the price of
cannabis are potential candidates for instruments. Given our approach, this would require data on
prices and policies from 1966 to the present since our oldest sample members are 50 in 2004 and
are assumed to be at risk of uptake from the age of 12. This information is simply not available
for cannabis prices. While it may be possible to construct this type of historical series for the legal
status of cannabis, it would vary insuciently for it to be useful since there are only eight states
and territories in Australia and the four that have decriminalised the consumption of cannabis
have done so rather recently.3 Empirical Strategy 13
oped by Mroz (1999) for application to regression models with endogenous dummy
variables.7 Mroz demonstrates that when the idiosyncratic error terms for the latent
endogenous variable and the outcome of interest have a bivariate normal disturbance,
the discrete factor method compares favorably to the usual Maximum Likelihood
Estimator (MLE) in terms of precision and bias. Furthermore, the discrete fac-
tor approximation outperforms both the MLE and the Two Stage estimator (TSE)
when the disturbances are non-normal.8
In our application, we use the discrete factor approach to account for the unob-
served factors eecting the production of mental health, cannabis uptake and quit-
ting in order to obtain reliable estimates of the mental health eects of cannabis use.
Identication of this trivariate model with correlated errors comes from functional
form assumptions. In the case of cannabis uptake and quitting, we follow Heckman
and Singer (1984) and assume mixed proportional hazard functions. Due to its cen-
sored nature, the equation for mental health is based on the Tobit model. Similar
to Mroz (1999), identication of unobserved heterogeneity in this equation relies on
the linearity of the model for the latent variable and normality of its idiosyncratic
error. As with any attempt to discern causal eects of endogenous variables, identi-
cation of the parameters of interest is ultimately based on untestable assumptions.
We have, however, attempted to explore issues related to identication and model
specication in an extensive sensitivity analysis that is reported in section 4.
Our estimation strategy is implemented in three steps. First, we jointly model
the cannabis uptake and quitting decisions. In doing so we pay particular atten-
7 In his set-up, Mroz interprets the discrete factors as an unobserved covariate that impacts
on the outcome of interest as well as the latent process generating the dummy variable, thereby
inducing its endogeneity.
8 The discrete factor model also outperforms MLE and TSE in the presence of weak instruments
in models with non-normal errors. This is of particular salience given that state level policy
variables are often relied upon to identify the eects of substance use and these policy variables
tend to be only weakly predictive of substance use.3 Empirical Strategy 14
tion to modeling the potentially correlated unobserved heterogeneity driving these
processes, which is assumed to come from a discrete distribution representing latent
proclivities towards cannabis use. In the second step we model the censored contin-
uous measure for mental health treating cannabis use as exogenous, but accounting
for unobserved heterogeneity with respect to susceptibility to mental illness using
the discrete factor approach. In the third step, we marry the bivariate hazard model
for cannabis uptake and quitting with the model for mental health, accounting for
common unobserved confounding factors by allowing for correlation in the unob-
served discrete factors determining the uptake and quitting of cannabis and the
production of mental health.
3.1 Dynamics in cannabis use
The rst part of our econometric strategy focusses on modeling the transitions into
and out of cannabis use. We model the rate of uptake of cannabis and the quit rate
from cannabis use with a bivariate mixed proportional hazard framework. Concern-
ing the uptake of cannabis we assume that potential exposure to cannabis occurs
from the age 12. The starting rate for cannabis use, at time (from age 12) t con-
ditional on observed characteristics x and unobserved characteristics u is specied
as
s(t j x;u) = s(t)exp(x
0s + u) (1)
where s(t) represents individual duration dependence and  represents a vector of
parameters to be estimated. Unobserved heterogeneity accounts for dierences in
susceptibility to cannabis. We model duration (age) dependence in a exible way by
using a step function s(t) = exp(kkIk(t)), where k (= 1,..,15) is a subscript for
age categories and Ik(t) are time-varying dummy variables that are one in subsequent
categories. We specify 15 age dummies, 14 of which are for individual ages (age 12,3 Empirical Strategy 15
13, .., 25) and the last interval is open: 26 years. Because we also estimate a
constant term, we normalize 1 = 0.
The conditional density function for the completed durations until rst use can
be written as
fs(t j x;u) = (t j x;u)exp( 
Z t
0
(s j x;u)ds) (2)
Individuals who initiate cannabis use have a completed duration until rst use equal
to the age at rst use minus 12; individuals who have not used cannabis at the time
of the survey have a duration until rst use that is right-censored at their current
age minus 12.
The quit rate from cannabis use at duration of use  conditional on observed
characteristics x, the age of rst use af, and unobserved characteristics v is specied
as
q( j x;af;v) = exp(x
0q + faf + v) (3)
where f and q represent parameters to be estimated. The conditional density
function for the completed durations of cannabis use can be written as
fq( j x;af;v) = q( j x;af;v)exp( 
Z 
0
q(r j x;af;v)dr: (4)
As we do not know the actual age at which individuals quit cannabis use we cannot
calculate the exact duration of use and hence cannot estimate the conditional density
for completed durations. However, we do know whether or not individuals used
cannabis in the 12 months before the survey. For those who had not, we know
that their duration of use, s, lies in the interval [0;as 1   af], where as is the
respondents age at the time of the survey and af is their age of rst use. We can
therefore account for the uncertainty over the exact age at quitting by integrating the
conditional density for durations of use over this range:
R s
0 fqdq = Fq(s j x;af;v),
where Fq is the distribution function of fq. Individuals who are still using cannabis3 Empirical Strategy 16
have a duration of use that is right censored and for these observations, we use the
survival function: 1   Fq(s j x;af;v).
Modeling the dynamics of cannabis use requires information about characteris-
tics and circumstances faced by individuals at each point in time in which they are
confronted with the choice to initiate or quit cannabis use. Information likely to be
relevant includes family situation, experiences at school, cannabis supply conditions,
the price of cannabis, and the price of other drugs (substitutes and complements).
Unfortunately, this type of information is not available in the NDSHS. We note how-
ever, that many of these factors are likely to be endogenous and it is therefore not
clear how one should proceed if they were available.9 The observable characteristics
that we are able to control for are nationality (an indicator for Australian born),
whether the respondent identies themselves as an Aboriginal or Torres Strait Is-
lander, whether they live in a capital city, birth year (to account for birth cohort
size eects), the respondent's state of residence at the time of survey and the re-
spondent's education (an indicator for dropping out of school with a 10th grade
education or less) which is used as a proxy for ability.10 These characteristics are
assumed to be known at the time an individual rst faces the decision of whether
to initiate cannabis use. In the case of the education variable, this requires the
assumption that education represents ability and that this ability is known to the
individual from the time he rst faces the decision to use cannabis. The educa-
tion variable will not fulll this requirement if, at the time an individual decides to
9 We do attempt to address the issue of greater vulnerability early in life in one of our sensitivity
analyses in section 4. Note that variables reecting the respondent's current circumstance, such
as marital status, that are collected as part of the NDSHS are not useful for modeling cannabis
uptake because they represent events that may have taken place long after the individual started
to use cannabis.
10 Jacobson (2004) nds a positive correlation between youth cohort size and the prevalence of
cannabis use which she largely attributes to a decreased costs of supply due to reduced risk of
arrest for selling and informational economies associated with a larger market.3 Empirical Strategy 17
start using cannabis, he is uncertain as to whether he will drop out of school before
completing 10th grade or, if there exist unobserved characteristics that impact both
educational attainment and cannabis use (see for example, Heckman, Stixrud and
Urzua (2006) who allow latent cognitive and noncognitive skills to determine edu-
cation and cannabis use). There is also the possibility of reverse causality in which
case cannabis use may result in dropping out of school. The impact of these issues
are examined in section 4.
The potential correlation between the unobserved components in the hazard
rates for cannabis uptake and quitting is taken into account by specifying the joint
density function for the duration until rst use t and the duration of time until
quitting use  conditional on x as
h(t;jx;af) =
Z
u
Z
v
fs(t j x;u)fq( j x;af;v)dG(u;v) (5)
where G(u;v) is a bivariate discrete distribution with n points of support. The
probabilities associated with each type are assumed to have a multinomial logit
specication: pj =
exp(j)
j exp(j), j = 1;::;n, with normalization n = 0.
The parameters of the model are estimated separately for males and females
using maximum likelihood and presented in Table 3. To select the number of points
of support in the joint distribution of discrete factors, an upward-testing approach is
used, starting with one point of support and adding additional points of support in
a stepwise manner. Beyond four points of support the locations of additional mass
points converged to each other and no improvement of the loglikelihood function was
found.11 The points of support reect the assumption that, conditional on observed
characteristics, there exist 4 distinct \types" of individuals who are dierentiated
by their susceptibility to starting and stopping cannabis use.12 Type 1, represented
11 The bottom part of Table 3 shows the loglikelihood values for the model with 1, 2, and 3 points
of support.
12 According to Gaure et al. (2007) it may not be meaningful to interpret the mass-point dis-3 Empirical Strategy 18
by (u1;v1), has a low starting rate and a positive quit rate, type 2, represented by
(u2;v2), has a high starting rate and a zero quit rate, type 3, represented by (u3), has
a zero starting rate (and hence no quit rate), while type 4, represented by (u1;v2),
has a low starting rate and a zero quit rate. As shown in Table 3, the distribution of
unobserved heterogeneity implies that 40.4% of the male sample and 48.4% of the
female sample fall into the group with a low starting rate and a positive quit rate,
7.9% of males and 3.5% of females belong to the group with a high starting rate
and a zero quit rate, while 41.6% of males and 43.7% of females have a zero starting
rate. Finally, 10.1% of the males and 4.4% of the females have a low starting rate
and a zero quit rate.
The results from estimation indicate that Australian born males and females
with a low level of education have a higher uptake of cannabis than foreign born
individuals or those with greater than a 10th grade education. Those born in more
recent years have a higher starting rate than those born earlier, and Aboriginal
females are less likely to initiate into cannabis use than other Australian females. In
terms of quit rates, we nd that females with a low level of education are less likely
to quit compared to those females with more than a 10th grade education. In line
with Van Ours and Williams (2007), we also nd that age of initiation has a large
eect on the quit rate with those initiating into cannabis use early in life having a
lower quit rate.
tribution in terms of representing a corresponding number of distinct types of individuals as the
underlying true heterogeneity distribution may be continuous. However, in the case of cannabis
use the interpretation in terms of types is more natural as starting to use cannabis is a discrete
choice as is quitting conditional on use.3 Empirical Strategy 19
3.2 Determinants of mental health assuming exogenous
cannabis use
Figure 2 shows that, in our sample, the distribution of K10 scores has a signicant
proportion of observations at the lower limit value of 10. It also shows that the
distribution of K10 scores is skewed to the right. To account for these features,
we model the production of mental health using a Tobit model for log (K10). The
natural log of latent mental health of individual i, m
i, is assumed to depend upon a
vector of observed characteristics xm, past and current cannabis use, and unobserved
characteristics :
m

i = x
0
mm + 1cci + 2cpi + i + i (6)
where cci is a dummy variable indicating whether or not an individual is a current
user of cannabis (has used in the past 12 months), cpi is a dummy variable indicating
whether an individual is a past user of cannabis (has used in lifetime but not in the
past 12 months) and m, 1 and 2 are parameters to be estimated. Observed
mental health, mi, is measured by the natural log of the K10 score.13 Given the
censoring point of 10 for the K10, the relationship between latent mental health
m
i and observed mental health mi is given by mi = log(10) if m
i  log(10) and
mi = m
i if m
i > log(10). The main parameters of interest are 1 and 2, which
measure the eect of current and past cannabis use on mental health, respectively.
The observed characteristics, xm, include the respondents age, their nationality
(an indicator for Australian born), whether the respondent identies themselves
as an Aboriginal or Torres Strait Islander, whether they live in a capital city, the
13 A priori it is not clear whether to use a linear or loglinear specication for the K10 score. We
used the pseudo R2 as guidance. The pseudo R2 is calculated as (1-Lu
L0 ), where Lu is the value of
the loglikelihood of the full model and L0 is the value of the loglikelihood of the model with only
an intercept. For the logarithmic specication we found a pseudo R2 of 0.062 both for males and
females; for the linear specication we found a pseudo R2 of 0.007 for males and 0.008 for females.3 Empirical Strategy 20
respondent's state of residence at the time of survey, the respondent's education
(an indicator for dropping out of school with a 10th grade education or less) and
their marital status (indicators for married and divorced with single or widowed
as the comparison category). As with the dynamics of cannabis use, there exists
the potential for unobserved characteristics that determine mental health to also
determine education and marital status. The sensitivity of our results to this issue
are explored below.
The error term for individual i is assumed to be composed of two components.
The rst is a a discrete factor i, which is intended to capture unobserved suscep-
tibility to mental illness. The second component of the error term is drawn from a
normal distribution, i  N(0;2). Since we do not have panel data, the identica-
tion of the discrete factor relies on the assumption that i is normally distributed.
As before we assume that the probabilities associated with the discrete factors
follow a logit specication. Table 4 contains the maximum likelihood estimates
of the relevant parameters. We found no improvement in the likelihood function
beyond two mass points, implying two distinct \types" in our sample.14 The rst
mass point is estimated to be 2.512 for males and 2.632 for females. This implies
K10 sores of 12.3 (exp(2.512)) and 13.9 (exp(2.632)) respectively. Since a K10 score
of less than 20 is indicative of an absence of mental illness, this group is considered
to have a low susceptibility to mental health problems. The second mass point is
3.089 for males and 3.203 for females, which translates in K10's of 22.0 and 24.6.
Given that a K10 score between 20 and 25 identies a person as having mild mental
health problem, those belonging to this group are considered to be susceptible to
mental health problems.
14 Note that the explanatory variables are specied as deviations from the mean. Also note that
the bottom part of Table 4 shows that the introduction of 2 mass points has a big eect on the
value of the log-likelihood while the estimated eects of cannabis use on mental health are very
similar to a specication without mass points.3 Empirical Strategy 21
Table 4 shows that, all else being equal, married respondents are in better men-
tal health than those who are single or widowed and that divorcees are in worse
mental health than those who are single or widowed. Younger respondents are, on
average in better mental health than their older counterparts, and Aboriginals are
in worse mental health than non-Aboriginals. We nd no evidence that a low level
of education is associated with worse mental health.
The main parameters of interest are those measuring the eects of current and
past cannabis use on mental health. As shown in Table 4, we nd that both men
and women who currently use cannabis have a higher K10 score than those who have
never used cannabis, where the increase in K10 attributable to current cannabis use
is similar in size and magnitude to the eect of a married person becoming divorced.
We also nd that past users of cannabis have a higher K10 score compared to their
counterparts who have never used. The increase in the K10 score attributable to
past use is around half of that associated with current use.
3.3 A joint model of cannabis use and mental health
In estimating the joint model for cannabis dynamics and the production of mental
health, we start by assuming that the distribution of unobserved heterogeneity has
eight points of support, reecting two types in terms of susceptibility to mental
illness combined with four types in terms of susceptibility to cannabis use. As before,
the associated probabilities are assumed to have a multinomial logit specication:
pj =
exp(j)
j exp(j), j = 1;::;8, with the normalization 8 = 0.
The three equation system is estimated using maximum likelihood and the rel-
evant estimates are presented in the rst panel of Table 5. We do indeed nd that
the joint distribution of unobserved heterogeneity for the cannabis starting and quit
rates and the production of mental health has 8 points of support. The vast majority
of the sample belong to two groups, each of which have a low susceptibility for men-4 Sensitivity analysis and simulations 22
tal health problems. For example, 36.9% of males and 41.4% of females belong to
the group characterized by a low positive cannabis starting rate, a positive cannabis
quit rate and low susceptibility to mental health problems (type 1) and 36.9% of
males and 38.1% of females have a zero cannabis starting rate and a low suscepti-
bility to mental illness (type 3). While this distribution demonstrates a correlation
between cannabis use and susceptibility to mental illness, the correlation does not
appear to be very strong. At the 10% level of signicance, a Likelihood Ratio test
(LR) of the null hypothesis of no correlation is rejected for men, conrming that
common unobserved factors is an issue for this sample. For women this is not the
case.
A comparison of the results from estimating models with and without account-
ing for common unobserved factors (comparing the rst panel of Table 5 and the
parameter estimates in Table 4) reveals that the causal eect of cannabis use on
mental health is overestimated if one doesn't account for these unobserved common
factors. This implies that those who are more likely to start using cannabis are
also more likely to have mental health problems. However, as shown the parameter
estimates representing the eect of current and past cannabis use on mental health
are not much aected by whether or not correlation in unobserved characteristics
is accounted for. From this we conclude that after accounting for the potentially
confounding eect of unobserved characteristics cannabis use has an adverse impact
on mental health. Moreover, while this eect is greater for current use, it persists
well after use ceases.
4 Sensitivity analysis and simulations
We next investigate the sensitivity of our ndings to assumptions made in modeling
the relationship between cannabis use dynamics and mental health. The results
from doing so are summarized in Table 5.4 Sensitivity analysis and simulations 23
First, we investigate the impact of recall error by estimating our model over the
subsample of 26-35 year olds. To the extent that respondents make mistakes in
the age they report rst using cannabis, our parameter estimates of the impact of
cannabis use on mental health based on the full sample and reported in Table 5
panel 1 are likely to be biased towards zero. We expect that recall error is less of a
problem amongst the 26-35 age group (as less calendar time has elapsed since they
rst used and perhaps quit cannabis) and hence results based on these data more
reliable. The results for this younger subsample are reported in Table 5 panel 2. A
comparison of results based on estimation over the full sample with those based on
the younger sample reveals no signicant dierences suggesting that recall error is
not an important source of bias in the data used in this analysis.
Second, we examine whether the impact of cannabis use on mental health varies
by age of rst use. Specically, we allow the eects of past and current use on mental
health to dier for those who rst used cannabis before the age of 16 and those who
were 16 or older when they rst tried cannabis. A Likelihood Ratio test is used to
examine the empirical support for eects that dier by age. As shown in the third
panel of Table 5, we nd signicant dierences in the impact of cannabis use on
mental health by the age of uptake for females but not males. Specically, we nd
that current and past use of cannabis produces signicantly greater increases in the
K10 score of females who rst used cannabis before the age of 16 compared to those
who rst used at 16 years or older.
We also investigate whether the mental health eects of current cannabis use
depend upon the frequency of use. To do so, we measured frequency of use in the
past year with a set of indicators for the categories use every day, use weekly, use
monthly, use every few months, and use once or twice a year, in addition to the
categories past use and never use. As shown, the mental health eects of cannabis
use increase with the frequency of use. For example, on average males who use4 Sensitivity analysis and simulations 24
once or twice a year have a K10 score which is similar to males who stopped using
cannabis, whereas males who use daily have a K10 score that is approximately 15.1
percent larger than a comparable male who has never used. For females, we nd
similar results.
In addition to the sensitivity analyses reported in Table 5, we also also investi-
gated the robustness of our results to several other aspects of model specication.
First, we examined the impact of the potential endogeneity of marital status and
education on the estimated eect of cannabis use on mental health. We did this by
comparing results from our baseline model (Table 5 panel 1) with estimates from
a model which omitted education and marital status from all three equations. The
estimated eects of cannabis use (past and current) are quite robust suggesting
this potential source of model mispecication is not driving our ndings. Second,
we allowed for more exible cohort eects by replacing the continuous year of birth
variable with indicators for birth cohort (born in the 1950s, the 1960s and the 1970s).
The results from this model are almost identical to those from the original speci-
cation. We also explored the potential for heterogeneity in treatment eects by
allowing all parameter estimates in the mental health equation to dier by whether
the individual was a never user, current user or past user of cannabis. On the basis
of an LR test we are unable to reject the null hypothesis of homogeneity in the
eects of cannabis use on mental health. Finally, we considered the sensitivity of
our results to specifying mental health as a continuous (censored) variable. As an
alternate approach we constructed an ordinal categorical variable for mental health
(no mental health problems, mild mental health problems, moderate mental health
problems and severe problems). The estimated eects from ordered probit models
of mental health are very similar to our baseline estimates in Table 5 panel 1.
In order to illustrate the impact of cannabis use on mental health as measured
by the K10 score, we use the parameter estimates contained in Table 5, panel 44 Sensitivity analysis and simulations 25
to perform simulations. We present scenarios in which individuals vary in their
frequency of cannabis use, ranging from never users (type 1) to daily cannabis users
(type 7) . All simulations are done separately for males and females. The results are
presented in Table 6.15 The simulations show that, for males, the impact of using
cannabis weekly or more often produces a substantial increase in the prevalence
of mental illness compared to those who have never used, used in the past, and
those who use less frequently. The prevalence of mental illness (K10  20) amongst
frequent cannabis using males (using weekly or more often) is predicted to be in the
range of 14.3 to 14.8%. In comparison, otherwise similar males who have never used
cannabis are predicted to have a prevalence of mental illness of 8.0%. This increase
occurs predominantly among the categories of mild (K10 between 20 and 24) and
severe (K10 of at least 30) mental illness. For example, Table 6 shows that the
prevalence of severe mental illness in males who use cannabis weekly (or daily) is
double that of males who have never used cannabis, at 2.4% compared to 0.9%. The
simulations also show that less frequent use of cannabis produces a small increase
in the prevalence of mental health problems, similar in magnitude to the increase
associated with past cannabis use. For example, the prevalence of severe mental
distress amongst those who use cannabis once a month is 1.5% compared to 1.4%
amongst past users. Intensity of use is found to have a similar eect on females,
except that using every few months rather than weekly appears to be the critical use
category and females generally experience a higher rate of mental health problems
compared to males.
15 The simulations assume that individuals are married, Australian born, non-Aboriginal aged
40 years old who have more than 10 years of education.5 Conclusions 26
5 Conclusions
Despite the widely held belief that cannabis is a benign drug, there is increasing
evidence of an association between its use and mental illness. Our paper investigates
the extent to which this association is causal. In order to do so, we account for the
potential for common unobserved factors aecting cannabis use and mental health.
We do this by modeling cannabis uptake and quitting jointly with the production
function for mental health, allowing the unobserved heterogeneity determining each
to be correlated. Our results suggest that cannabis use does have an adverse eect
on mental health, with frequent current use having a larger eect than infrequent
current use or past use. We also nd that unobserved factors that make individuals
more susceptible to cannabis use also make them more susceptible to mental illness.
While accounting for common unobserved factors reduces the size of the estimated
eects of current and past cannabis use on mental health, it does not eliminate
them.
It should be reiterated that our ndings are subject to caveats related to lim-
itations of our data and assumptions underlying our identication strategy. For
example, due to the absence of information on the age of onset of mental health
problems, this study has focussed on common unobserved factors as the source of
the endogeneity of cannabis use in the production of mental health. Reverse causal-
ity remains a potential issue, although previous studies suggest that its eects are
likely to be small. A second shortcoming of the data is that the information on age
at rst use of cannabis is retrospectively reported and potentially subject to report-
ing errors. We attempt to investigate this issue as part of our sensitivity analysis
and nd no evidence that, for our sample, this is an important source of bias in
our estimates. As part of our extensive sensitivity analysis, we also investigated
the impact of modeling assumptions including the functional form of the mental
health equation and homogeneity of treatment eects. Overall, we found our results5 Conclusions 27
to be very robust and, within the limitation of this type of research, indicate that
cannabis use leads to worse mental health. We nd that frequent cannabis use poses
the greatest risk to mental health. This has wide ranging implications not just for
the individuals (and their families) but also for the wider society. Mental illness
imposes sizable costs on the economy, the most signicant of which is attributable
to loss in productivity. While these results are striking, it is nonetheless important
to emphasize that only frequent cannabis use is found to cause large increases in
the likelihood of mental illness, and only a fraction of cannabis users fall into this
category.5 Conclusions 28
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Tab. 1: Means of variables
Variable Males Females
Ever used cannabis 0.58 0.49
Age rst used cannabis (conditional on ever using) 18.4 18.7
Cannabis use before age 16 0.12 0.09
Cannabis use in past 12 months 0.20 0.11
Intensity of cannabis use in past 12 months (%)
{ Once or twice a year 5.2 3.7
{ Every few months 2.9 1.5
{ About once a month 2.2 1.3
{ Once a week or more 5.3 2.4
{ Every day 4.6 1.7
K10 score 14.8 15.5
K10 indicator for mental health problem 0.14 0.17
Age 38.4 37.9
Born in Australia 0.76 0.79
Aboriginal or Torres Strait Islander 0.02 0.02
Married 0.68 0.70
Divorced 0.10 0.14
Highest qualication is year 10 certicate 0.16 0.24
Victoria 0.22 0.23
Queensland 0.18 0.19
South Australia 0.08 0.08
Western Australia 0.11 0.10
Tasmania 0.04 0.04
Australian Capital Territory 0.05 0.04
Northern Territory 0.05 0.05
Lives in a capital city 0.65 0.64
N 4771 67196 Tables and graphs 33
Tab. 2: Mental illness conditional on cannabis use
K10 score Never used Past user Current user
a. Males
No mental health problem < 20 0.89 0.87 0.79
Mental health problem  20 0.11 0.13 0.21
of which
Mild 20-24 0.08 0.08 0.13
Moderate 25-29 0.04 0.03 0.04
Severe  30 0.02 0.02 0.04
b. Females
No mental health problem < 20 0.86 0.81 0.71
Mental health problem  20 0.14 0.19 0.29
of which
Mild 20-24 0.08 0.11 0.16
Moderate 25-29 0.04 0.05 0.08
Severe  30 0.02 0.03 0.056 Tables and graphs 34
Tab. 3: Parameter estimates dynamics in cannabis use
Males Females
Starting rate Quit rate Starting rate Quit rate
4 masspoints
Explanatory variables
Australian born 0.22 (4.3)** -0.07 (0.3) 0.45 (7.5)** 0.13 (1.1)
Aboriginal -0.21 (1.5) -0.35 (0.4) -0.24 (1.9)* 0.05 (0.2)
Education  10 0.09 (1.7)* 0.38 (1.1) 0.19 (3.7)** -0.26 (2.3)**
Birthyear/10 0.44 (13.8)** -0.45 (1.7)* 0.78 (22.8)** 0.10 (0.7)
Age of initiation/10 { 0.80 (3.2)** { 0.61 (5.1)**
Mass points
u1;v1 -6.05 (33.4)** 0.30 (0.3) -7.12 (30.1)** -1.27 (2.4)**
u2;v2 -3.24 (17.6)**  1 -4.33 (17.8)**  1
u3  1 {  1 {
1 1.39 (16.4)** 2.39 (8.4)**
2 -0.24 (2.0)** -0.24 (0.9)
3 1.42 (18.3)** 2.29 (8.7)**
Distribution (%)
p1(u1;v1) 40.4 48.4
p2(u2;v2) 7.9 3.5
p3(u3) 41.6 43.7
p4(u1;v2) 10.1 4.4
-Loglikelihood 11,437.6 14,252.2
-Loglikelihood
1 masspoints 11,796.3 14,524.3
2 masspoints 11,565.8 14,341.4
3 masspoints 11,453.6 14,256.8
Note: Sample of 4771 males and 6719 females aged 26 to 50; all estimates include territories
xed eects (7) and a dummy for capital cities both in the starting rates and in the quit
rates; note that the starting rates for cannabis use contains 14 age dummies (annually
13-25 and >25 years); absolute t-statistics in parentheses; a ** (*) indicates that the
coecient is dierent from zero at a 5% (10%) level of signicance.6 Tables and graphs 35
Tab. 4: Parameter estimates mental health { log K10
Males Females
a. 2 masspoints
Explanatory variables
Age/10 -0.027 (3.9)** -0.020 (3.6)**
Australian born -0.013 (1.2) -0.004 (0.5)
Aboriginal 0.107 (3.4)** 0.062 (2.4)**
Married -0.062 (5.5)** -0.062 (6.1)**
Divorced 0.052 (3.2)** 0.030 (2.0)**
Education  10 0.009 (0.7) -0.003 (0.4)
Eect cannabis use
{ still using 0.120 (9.8)** 0.131 (10.6)**
{ stopped using 0.059 (5.8)** 0.067 (8.3)**
 0.264 (47.1)** 0.249 (64.7)**
Mass points
1 2.512 (276.8)** 2.632 (119.1)**
2 3.089 (101.4)** 3.203 (120.1)**
1 2.125 (13.8)** 1.830 (20.9)**
Distribution (%)
p1 89.3 86.2
p2 9.7 13.8
-Loglikelihood 2005.9 2485.9
b. 1 masspoint
Eect cannabis use
{ still using 0.122 (9.2)** 0.140 (10.2)**
{ stopped using 0.057 (5.1)** 0.069 (7.8)**
-Loglikelihood 2059.9 2618.4
Note: Sample of 4771 males and 6719 females; in all estimates the explanatory variables
are specied as deviations from their mean value and they include territories xed eects
(7) and a dummy for capital cities; a ** (*) indicates that the coecient is dierent from
zero at a 5% (10%) level of signicance.6 Tables and graphs 36
Tab. 5: Eects cannabis use on log K10 score
Males Females
1. Baseline estimate  p (%)  p (%)
(u1;v1;1) 3.202 (13.6)** 36.9 3.972 (10.4)** 41.4
(u2;v2;1) 1.479 (5.7)** 6.6 1.208 (3.1)** 2.6
(u3;1) 3.203 (13.6)** 36.9 3.890 (10.5)** 38.1
(u1;v2;1) 1.741 (6.7)** 8.6 1.589 (4.3)** 3.8
(u1;v1;2) 0.865 (3.3)** 3.6 2.147 (5.4)** 6.7
(u2;v2;2) -0.191 (0.6) 1.2 0.047 (0.1) 0.8
(u3;2) 1.168 (4.8)** 4.8 2.011 (5.2)** 5.8
(u1;v2;2) { 1.5 { 0.8
Cannabis { still using 0.107 (6.8)** 0.112 (6.8)**
Cannabis { stopped using 0.070 (5.6)** 0.065 (6.6)**
LR-test selectivity 7.4* 5.6
2. Age  35
Cannabis { still using 0.112 (5.3)** 0.097 (4.0)**
Cannabis { stopped using 0.052 (2.6)** 0.063 (3.8)**
3. By age of initiation
 15
Cannabis { still using 0.105 (4.4)** 0.132 (4.8)**
Cannabis { stopped using 0.101 (4.8)** 0.119 (6.8)**
> 15
Cannabis { still using 0.109 (6.3)** 0.103 (5.6)**
Cannabis { stopped using 0.066 (5.1)** 0.057 (5.6)**
LR-test age specicity 2.8 15.0**
4. Intensity of cannabis use
{ Every day 0.151 (6.5)** 0.191 (6.2)**
{ Once a week or more 0.143 (6.0)** 0.131 (4.7)**
{ About once a month 0.080 (2.4)** 0.115 (3.4)**
{ Every few months 0.060 (2.1)** 0.109 (3.3)**
{ Once or twice a year 0.066 (2.7)** 0.078 (3.3)**
{ Stopped using 0.069 (5.6)** 0.065 (6.6)**
LR-test intensity matters 13.6** 8.4*
Note: the parameter estimates for the starting rates, quit rates and the other parameter
estimates for mental health are not reported because they are similar to those in Tables 3
and 4; all estimates contain 8 masspoints except the estimates for young females (age  35)
where we could only identify 6 mass points. Sample of 4771 males and 6719 females except
for estimate 2: 1791 males and 2756 females; absolute t-statistics in parentheses; a ** (*)
indicates that the coecient is dierent from zero at a 5% (10%) level of signicance.6 Tables and graphs 37
Tab. 6: Results simulations eects cannabis use on K10-score; dierent
types of individuals (%)
1 2 3 4 5 6 7
Males
10 24.6 17.4 17.7 18.2 16.4 11.3 10.7
10-20 67.4 72 71.8 71.5 72.5 74.4 74.5
20-25 5.2 6.6 6.5 6.5 6.9 8.6 8.9
25-30 1.9 2.6 2.6 2.4 2.7 3.4 3.5
 30 0.9 1.4 1.4 1.4 1.5 2.3 2.4
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Females
10 20.8 14.4 13.3 10.9 10.6 9.4 6.1
10-20 69.5 73.2 73.7 74.5 74.6 74.8 74.2
20-25 6.2 7.5 7.8 8.6 8.6 9.2 11.2
25-30 2.4 3.2 3.3 3.7 3.8 4 4.8
 30 1.1 1.7 1.9 2.3 2.4 2.6 3.7
Total 100.0 100.0 100.0 100.0 100.0 100.0 100.0
Individual: Australian born, non-Aboriginal individual age 40 having an education of
more than 10 years and married; Types of cannabis users:
1 = Never used cannabis
2 = Stopped using cannabis
3 = Uses cannabis one or twice a year
4 = Uses cannabis every few months
5 = Uses cannabis about once a month
6 = Uses cannabis once a week or more
7 = Uses cannabis every day6 Tables and graphs 38
Fig. 1: Hazard of starting cannabis use by gender (annual percentages)
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Fig. 2: K10 score (percentages)
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